CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- 4 Grant or award CHIEF LEGAL OFFICER, SECRETARY acquired 1,448 shares (grant or award)
- 4 Open-market buy Director bought 57,965 shares at $2.13 ($123,436)
- 4 Open-market buy Director bought 75,000 shares at an average $2.44 ($183,058)
- 4 Open-market buy PRESIDENT AND CEO bought 20,000 shares at $2.77 ($55,326)
- 4 Open-market sale 10% owner sold 909,091 shares at an average $3.02 ($2,749,003)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 9 · 166 filings